MRI-Derived Pressure Ratio: a Novel Noninvasive Hemodynamic Biomarker for Stroke Risk Stratification in Intracranial Atherosclerotic Stenosis

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY

Intracranial atherosclerotic stenosis (ICAS) carries substantial stroke risk despite optimal medical treatment. Current risk stratification relies primarily on stenosis severity, but novel hemodynamic markers may improve prediction. In this multiple prospective registry study we aim to investigate whether regional hemodynamics, measured by a novel Magnetic resonance imaging-derived Pressure Ratio (MPR) technique, are associated with stroke risk in ICAS.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Adults aged 18 to 80 years.

• Intracranial atherosclerotic stenosis ICAS involving a culprit artery in the anterior circulation.

• Intracranial arterial stenosis of 50% to 99% as measured by the WASID method using TCD, CTA, MRA, or DSA.

• Written informed consent obtained from the participant or a legal representative.

Locations
Other Locations
China
Department of Neurosurgery, Xuanwu hospital
RECRUITING
Beijing
Contact Information
Primary
Jichang Luo, M.D.
luojichang_dr@sina.com
+86 13120136577
Time Frame
Start Date: 2025-12-01
Estimated Completion Date: 2028-03-31
Participants
Target number of participants: 400
Treatments
CASSISS-MPR
Related Therapeutic Areas
Sponsors
Collaborators: Xuanwu Xiongan Hospital, Xuanwu Chifeng Hospital, Xuanwu Jinan Hospital, Xuanwu Hebei Hospital
Leads: Xuanwu Hospital, Beijing

This content was sourced from clinicaltrials.gov